KR970704468A - 폴리에피토프 백신(polyepitope vaccines) - Google Patents
폴리에피토프 백신(polyepitope vaccines)Info
- Publication number
- KR970704468A KR970704468A KR1019970700521A KR19970700521A KR970704468A KR 970704468 A KR970704468 A KR 970704468A KR 1019970700521 A KR1019970700521 A KR 1019970700521A KR 19970700521 A KR19970700521 A KR 19970700521A KR 970704468 A KR970704468 A KR 970704468A
- Authority
- KR
- South Korea
- Prior art keywords
- polyepitope vaccines
- polyepitope
- vaccines
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPM7079A AUPM707994A0 (en) | 1994-07-27 | 1994-07-27 | Polyepitope vaccines |
AUPN1009A AUPN100995A0 (en) | 1995-02-08 | 1995-02-08 | Polyepitope vaccines |
PCT/AU1995/000461 WO1996003144A1 (en) | 1994-07-27 | 1995-07-27 | Polyepitope vaccines |
Publications (1)
Publication Number | Publication Date |
---|---|
KR970704468A true KR970704468A (ko) | 1997-09-06 |
Family
ID=25644721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019970700521A KR970704468A (ko) | 1994-07-27 | 1997-01-27 | 폴리에피토프 백신(polyepitope vaccines) |
Country Status (9)
Country | Link |
---|---|
US (1) | US20070172461A1 (ko) |
EP (1) | EP0769963A4 (ko) |
JP (2) | JPH10506004A (ko) |
KR (1) | KR970704468A (ko) |
CN (1) | CN1180843C (ko) |
CA (1) | CA2195642A1 (ko) |
HK (1) | HK1002055A1 (ko) |
NZ (1) | NZ290089A (ko) |
WO (1) | WO1996003144A1 (ko) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPN443995A0 (en) * | 1995-07-27 | 1995-08-17 | Csl Limited | Papillomavirus polyprotein |
GB9517758D0 (en) * | 1995-08-31 | 1995-11-01 | Imutran Ltd | Compositions and their uses |
GB9711957D0 (en) * | 1997-06-09 | 1997-08-06 | Isis Innovation | Methods and reagents for vaccination |
AUPO784197A0 (en) | 1997-07-10 | 1997-08-07 | Csl Limited | Treatment of nasopharyngeal carcinoma |
AU1387299A (en) * | 1997-11-12 | 1999-05-31 | Valentis, Inc. | Expression plasmids for multiepitope nucleic acid-based vaccines |
TWI239847B (en) | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
US7964192B1 (en) | 1997-12-02 | 2011-06-21 | Janssen Alzheimer Immunotherapy | Prevention and treatment of amyloidgenic disease |
US20080050367A1 (en) | 1998-04-07 | 2008-02-28 | Guriq Basi | Humanized antibodies that recognize beta amyloid peptide |
GB9808932D0 (en) * | 1998-04-27 | 1998-06-24 | Chiron Spa | Polyepitope carrier protein |
GB9930616D0 (en) | 1999-12-24 | 2000-02-16 | Mathilda & Terence Kennedy Ins | Activation and inhibition of the immune system |
DK1242108T3 (da) * | 1999-12-28 | 2007-11-12 | Pharmexa Inc | Optimerede minigener og peptider kodet derved |
DE60116371T3 (de) | 2000-11-23 | 2016-11-17 | Bavarian Nordic A/S | Variante des modifizierten vaccinia ankara virus |
JP2004522432A (ja) | 2000-12-22 | 2004-07-29 | シノヴィス・リミテッド | Toll関連レセプター(trr)シグナル伝達の調節方法 |
WO2003008537A2 (en) * | 2001-04-06 | 2003-01-30 | Mannkind Corporation | Epitope sequences |
GB0118532D0 (en) | 2001-07-30 | 2001-09-19 | Isis Innovation | Materials and methods relating to improved vaccination strategies |
DE60238864D1 (de) | 2001-11-07 | 2011-02-17 | Mankind Corp | Für epitope von antigenen kodierende expressionsvektoren und verfahren zu deren konzeption |
ES2545090T3 (es) | 2001-12-21 | 2015-09-08 | Human Genome Sciences, Inc. | Proteínas de fusión de albúmina y GCSF |
MY139983A (en) | 2002-03-12 | 2009-11-30 | Janssen Alzheimer Immunotherap | Humanized antibodies that recognize beta amyloid peptide |
AU2002950183A0 (en) * | 2002-07-12 | 2002-09-12 | The Council Of The Queensland Institute Of Medical Research | Expression of hydrophobic proteins |
US8067535B2 (en) | 2003-01-24 | 2011-11-29 | The University Of Massachusetts | Identification of gene sequences and proteins involved in vaccinia virus dominant T cell epitopes |
US7217526B2 (en) | 2003-01-24 | 2007-05-15 | University Of Massachusetts Medical School | Identification of gene sequences and proteins involved in vaccinia virus dominant T cell epitopes |
US8916165B2 (en) | 2004-12-15 | 2014-12-23 | Janssen Alzheimer Immunotherapy | Humanized Aβ antibodies for use in improving cognition |
EP1717245B1 (en) | 2005-04-26 | 2011-06-08 | Immatics Biotechnologies GmbH | T-cell epitopes from the oncofetal antigen-immature laminin receptor protein and medical uses thereof |
ATE440107T1 (de) | 2005-09-05 | 2009-09-15 | Immatics Biotechnologies Gmbh | Tumorassoziierte peptide, die hla klasse i oder ii-moleküle binden, und anti-tumor impfstoffe |
EP1806359B1 (en) | 2005-09-05 | 2010-03-17 | Immatics Biotechnologies GmbH | Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules |
US8784810B2 (en) | 2006-04-18 | 2014-07-22 | Janssen Alzheimer Immunotherapy | Treatment of amyloidogenic diseases |
GB0706070D0 (en) * | 2007-03-28 | 2007-05-09 | Scancell Ltd | Nucleic acids |
US8003097B2 (en) | 2007-04-18 | 2011-08-23 | Janssen Alzheimer Immunotherapy | Treatment of cerebral amyloid angiopathy |
PL2182983T3 (pl) | 2007-07-27 | 2014-10-31 | Janssen Alzheimer Immunotherap | Leczenie chorób amyloidowych z wykorzystaniem humanizowanych przeciwciał specyficznych względem Abeta |
JO3076B1 (ar) | 2007-10-17 | 2017-03-15 | Janssen Alzheimer Immunotherap | نظم العلاج المناعي المعتمد على حالة apoe |
US20110110974A1 (en) * | 2007-10-29 | 2011-05-12 | Erik Depla | Methods and kits for inducing a ctl response using a prime boost regimen |
US9067981B1 (en) | 2008-10-30 | 2015-06-30 | Janssen Sciences Ireland Uc | Hybrid amyloid-beta antibodies |
CN102151332A (zh) * | 2011-03-22 | 2011-08-17 | 中国药科大学 | 一种幽门螺旋杆菌表位疫苗及其设计、制备方法和应用 |
CN104306995B (zh) * | 2014-10-29 | 2017-04-12 | 山东农业大学 | 一种抗j亚群禽白血病病毒感染的表位疫苗及其制备方法和应用 |
EP3484525A4 (en) * | 2016-07-18 | 2020-07-29 | The Council of the Queensland Institute of Medical Research | MULTIVIRUS-SPECIFIC T-LYMPHOCYTES IMMUNOTHERAPY |
CN109575141A (zh) * | 2017-09-29 | 2019-04-05 | 苏州工业园区唯可达生物科技有限公司 | 一种cd4辅助性t细胞表位融合肽及其疫苗 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5124440A (en) * | 1986-11-24 | 1992-06-23 | The Childrens Hospital, Inc. | Antibody and T cell recognition sites on glycoproteins comprising the GCI complex of human cytomegalovirus |
US6294322B1 (en) * | 1988-01-26 | 2001-09-25 | The United States Of America As Represented By The Department Of Health And Human Services | Multideterminant peptides that elicit helper T-lymphocyte cytotoxic T-lymphocyte and neutralizing antibody responses against HIV-1 |
US5703055A (en) * | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
US5045320A (en) * | 1989-03-23 | 1991-09-03 | Medical Biology Institute | Large multivalent immunogen |
AU2699192A (en) * | 1991-10-16 | 1993-05-21 | University Of Saskatchewan | Enhanced immunogenicity using leukotoxin chimeras |
US5580563A (en) * | 1992-05-01 | 1996-12-03 | Tam; James P. | Multiple antigen peptide system having adjuvant properties, vaccines prepared therefrom and methods of use thereof |
US5980899A (en) * | 1992-06-10 | 1999-11-09 | The United States Of America As Represented By The Department Of Health And Human Services | Identification of peptides that stimulate hepatitis C virus specific cytotoxic T cells |
US5683695A (en) * | 1993-02-10 | 1997-11-04 | United Biomedical, Inc. | Production of recombinant proteins containing multiple antigenic determinants linked by flexible hinge domains |
US5656465A (en) * | 1994-05-04 | 1997-08-12 | Therion Biologics Corporation | Methods of in vivo gene delivery |
-
1995
- 1995-07-27 CA CA002195642A patent/CA2195642A1/en not_active Abandoned
- 1995-07-27 WO PCT/AU1995/000461 patent/WO1996003144A1/en not_active Application Discontinuation
- 1995-07-27 NZ NZ290089A patent/NZ290089A/xx unknown
- 1995-07-27 CN CNB951943685A patent/CN1180843C/zh not_active Expired - Fee Related
- 1995-07-27 JP JP8505321A patent/JPH10506004A/ja not_active Withdrawn
- 1995-07-27 EP EP95926333A patent/EP0769963A4/en not_active Ceased
-
1997
- 1997-01-27 KR KR1019970700521A patent/KR970704468A/ko not_active Application Discontinuation
-
1998
- 1998-01-05 HK HK98100037A patent/HK1002055A1/xx not_active IP Right Cessation
-
2004
- 2004-07-02 US US10/884,183 patent/US20070172461A1/en not_active Abandoned
-
2007
- 2007-01-15 JP JP2007006075A patent/JP2007135598A/ja not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
US20070172461A1 (en) | 2007-07-26 |
WO1996003144A1 (en) | 1996-02-08 |
CN1154069A (zh) | 1997-07-09 |
NZ290089A (en) | 1999-05-28 |
EP0769963A4 (en) | 1999-07-28 |
JP2007135598A (ja) | 2007-06-07 |
HK1002055A1 (en) | 1998-07-31 |
EP0769963A1 (en) | 1997-05-02 |
CA2195642A1 (en) | 1996-02-08 |
CN1180843C (zh) | 2004-12-22 |
JPH10506004A (ja) | 1998-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR970704468A (ko) | 폴리에피토프 백신(polyepitope vaccines) | |
BR9711853A (pt) | Vacinas | |
ATE209045T1 (de) | Hepatitis b impfstoff | |
NO20003302L (no) | Vaksine | |
ATA166795A (de) | Bis-resorcinyltriazine | |
ATA163695A (de) | 2-hydroxyphenyltriazine | |
DE69529223D1 (de) | Prüfverfahren | |
DE69509766D1 (de) | Mikroemulsionen | |
ATA108995A (de) | Differenzdruckakkumulator | |
DE69524109D1 (de) | Zentriervorrichtung | |
IT1276662B1 (it) | Vaccini polinucleotidici | |
DE69524350D1 (de) | Analog-Digitalumsetzer | |
ATA11894A (de) | Stauförderbahn | |
KR950031796U (ko) | 꽃다발 장식체 | |
KR970703417A (ko) | 유두종 바이러스 백신(Papillomavirus vaccines) | |
BR7400683U (pt) | Odontoportátil | |
FI944558A0 (fi) | Virus | |
SE9403065D0 (sv) | Hållaranordning | |
SE9402881D0 (sv) | Hållaranordning | |
FI1887U1 (fi) | Campingkoek (campingutrustning) | |
KR950033601U (ko) | 에어브리더(Air-Breather) | |
CA74365S (fr) | Drap-housse (fitted bedsheet) | |
NO943938D0 (no) | Avstandselement | |
FIU940102U0 (fi) | Justerbar inpassningsdetalj | |
UA741S (uk) | Літак |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |